Remyelinating and neuroprotective treatments in multiple sclerosis.

about

Diffusion tensor imaging, structural connectivity, and schizophrenia Developing therapeutics for the treatment of multiple sclerosis Schizophrenia, myelination, and delayed corollary discharges: a hypothesis.

P2860

Q30560242-A7B13848-1587-4C05-951A-791A9B8D035A Q33946995-1FE8F21E-F14A-429C-9476-244595945B8C Q35898741-EFC04C3E-81BB-45BF-A2EB-671F5F0D7E35

P2860

Remyelinating and neuroprotective treatments in multiple sclerosis.

Item

http://www.wikidata.org/entity/Q35753458

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Remyelinating and neuroprotective treatments in multiple sclerosis.

@ast

Remyelinating and neuroprotective treatments in multiple sclerosis.

@en

type

Item

label

Remyelinating and neuroprotective treatments in multiple sclerosis.

@ast

Remyelinating and neuroprotective treatments in multiple sclerosis.

@en

prefLabel

Remyelinating and neuroprotective treatments in multiple sclerosis.

@ast

Remyelinating and neuroprotective treatments in multiple sclerosis.

@en

P1476

Remyelinating and neuroprotective treatments in multiple sclerosis.

@en

P2093

Martin Stangel

http://www.w3.org/2001/XMLSchema#string

P2860

Ultrastructural study of remyelination in an experimental lesion in adult cat spinal cord

Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system

Multiple sclerosis

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration

Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis

Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model

Neuregulin: an oligodendrocyte growth factor absent in active multiple sclerosis lesions

A monoclonal autoantibody which promotes central nervous system remyelination is highly polyreactive to multiple known and novel antigens

Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum

P304

331-347

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.13.4.331

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15102584

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

Remyelinating and neuroprotective treatments in multiple sclerosis.

about

P2860

P2860

Remyelinating and neuroprotective treatments in multiple sclerosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921